Top-Rated Breast Cancer Charities for 2024
Top-Rated Breast Cancer Charities for 2024
Oct 24, 2024
October is Breast Cancer Awareness Month.
October is Breast Cancer Awareness Month.
Top-Rated Charity
View similar charities
Ratings & Metrics
Financial Documents
| Entity | Document Type | Tax ID |
|---|---|---|
| Ovarian Cancer Research Alliance | Consolidated Audited Financial Statements | Multiple |
| Ovarian Cancer Research Alliance | IRS Form 990 | 13-3806788 |
|
Entity: Ovarian Cancer Research Alliance Document Type: Consolidated Audited Financial Statements Tax ID: Multiple |
|
Entity: Ovarian Cancer Research Alliance Document Type: IRS Form 990 Tax ID: 13-3806788 |
Governance & Transparency
CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
Top Salaries
| Name | Title | Compensation | |
|---|---|---|---|
| 1 | Audra L. Moran | President / CEO | $345,710 |
| 2 | Jonathan Zeidman | Chief Development Officer | $233,344 |
| 3 | Bibi Ali | Chief Financial Officer | $230,353 |
|
1 Name: Audra L. Moran Title: President / CEO Compensation: $345,710 |
|
2 Name: Jonathan Zeidman Title: Chief Development Officer Compensation: $233,344 |
|
3 Name: Bibi Ali Title: Chief Financial Officer Compensation: $230,353 |
Analysts' Notes
CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.
According to the Ovarian Cancer Research Alliance consolidated audit of December 31, 2023 (Note 1, Nature of Operations): "The Ovarian Cancer Research Fund, Inc. (OCRF) D/B/A Ovarian Cancer Research Alliance ('OCRA') is a corporation which was organized in the State of New York as a not-for-profit entity on December 8, 1994. OCRA executed a D/B/A on October 3, 2018 to assume the name Ovarian Cancer Research Alliance. OCRA previously operated as the Ovarian Cancer Research Fund Alliance (OCRFA), which name was adopted on January 1, 2016, the date on which the operations of the Ovarian Cancer National Alliance (OCNA) were consolidated with OCRF..." |
According to the Ovarian Cancer Research Alliance (OCRA) consolidated audit of December 31, 2023 (Note 2 re: Contributed Services), OCRA received in-kind "contributed services for advertising services and professional fees that were utilized principally in OCRA's program operations" during 2023 on which it placed a total value of $675,638. [Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.] |
According to the Ovarian Cancer Research Alliance consolidated audit of December 31, 2023 (Note 3, Concentrations of Credit Risk): "...One donor represents approximately 21% and 43% of contribution revenue for the years ended December 31, 2023 and 2022, respectively." |